Vanessa
Yen

Experienced with bench and jury patent trials before U.S. district courts, the U.S. Court of Appeals for the Federal Circuit and the PTAB, Vanessa has deep litigation experience handling pharmaceutical and biologics/biosimilars patent litigations, including for blockbuster products with multi-billion dollar sales. She has handled IP matters concerning various technologies, including products and treatments for cancer, HIV/AIDS, skin care and dermatology, femtech, prostate disorders, genetic vector technology and molecular cloning, musculoskeletal disorders, autoimmune and neurological disorders.

Named as one of the Top Women Attorneys in New York metro and a Top Rated Intellectual Property Litigation Attorney, Vanessa provides her clients with an array of IP services beyond patent litigation, including licensing and due diligence advice, strategic assessment of IP assets and IP portfolios for potential mergers & acquisitions, freedom to operate opinions, and others.

Vanessa has handled one of the Top Litigations and Disputes of 2019 (recognized by Financial Times) and achieved a patent litigation victory that was named Hatch Waxman Impact Case of the Year (recognized by LMG Life Sciences). She was also part of the team that obtained the first IPR victory for an Orange Book-listed patent dispute that was involved in parallel Federal district court litigation.

Committed to diversity and inclusion, Vanessa co-leads K&S's Asian Affinity Group, and is an active member of NAPABA, GABAPA, AALDEF and AABANY.

Prior to law, Vanessa spent years conducting breast cancer research and genetics/genomic research while at MIT.  She also worked at a top U.S. strategic management consulting firm.